This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
Company | Broker Update |
Alent | Goldman Sachs TP 426p: Buy |
Balfour Beaty | HSBC cuts TP to 260p from 285p; Neutral |
HSBC | Goldman Sachs ups TP to 950p from 940p; Buy/Neutral |
Icap | JPMorgan cuts TP to 344p from 355p: Neutral |
IG Group | Investec ups TP to 700p from 560p: Buy |
Invensys | Barcalys ups TP to 465p from 425p: Overweight |
ITE Group | Goldman Sachs ups TP to 380p from 365p: Removes from Conviction buy list to Buy |
London Stock Exchange | JPMorgan ups TP to 1244p from 1233p: Underweight |
Mitie Group | HSBC ups TP to 260p from 288p; Neutral |
Pennon Group | SocGen ups TP to 695p from 682p: Hold |
Phoenix IT | N+1 Singer upgrades to Hold from Sell |
Sepura | Liberum ups TP to 130p from 115p: Buy |
Serco Group | HSBC downgrades to Underweight from Neutral: TP 590p maintained |
Smiths Group | HSBC ups TP to 1550p from 1400p: Overweight |
Smiths Group | Citigroup ups TP to 1270p from 1020p: Sell |
Standard Chartered | Macquarie cuts TP to 1875.43p from 1992.80p: Outperform |
William Hill | Panmure Gordon ups TP to 518p from 475p: Buy |
Source: Reuters News, AlphaTerminal, Dow Jones Newswires |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research